Microbot Medical Addresses Misinformation
Analysis based on 6 articles · First reported May 15, 2026 · Last updated May 15, 2026
The market is impacted as Microbot Medical is proactively addressing negative claims, which could restore investor confidence and potentially stabilize or increase its stock price. The involvement of medical professionals like Charles Breyer and Zachary L. Bercu in refuting claims adds credibility, which is generally positive for the company's market perception.
Microbot Medical announced it will host an analysts and investors conference call on May 18, 2026, to address misleading statements and misrepresentations made in a recent unaffiliated third-party article. The call will also review the progress of the Full Market Release of its LIBERTY Endovascular Robotic System. Harel Gadot, Chairman, CEO & President of Microbot Medical, will lead the call, joined by Dr. Charles Breyer from Tampa General Hospital and Dr. Zachary L. Bercu from Emory Healthcare, both users of the LIBERTY System. They will share their experiences and correct inaccuracies attributed to them in the article, aiming to fully inform the investing public.
Set up alerts, explore entity relationships, search across thousands of events, and build custom intelligence feeds.
Open Dashboard